WAF1, a potential mediator of p53 tumor suppression
- PMID: 8242752
- DOI: 10.1016/0092-8674(93)90500-p
WAF1, a potential mediator of p53 tumor suppression
Abstract
The ability of p53 to activate transcription from specific sequences suggests that genes induced by p53 may mediate its biological role as a tumor suppressor. Using a subtractive hybridization approach, we identified a gene, named WAF1, whose induction was associated with wild-type but not mutant p53 gene expression in a human brain tumor cell line. The WAF1 gene was localized to chromosome 6p21.2, and its sequence, structure, and activation by p53 was conserved in rodents. Introduction of WAF1 cDNA suppressed the growth of human brain, lung, and colon tumor cells in culture. Using a yeast enhancer trap, a p53-binding site was identified 2.4 kb upstream of WAF1 coding sequences. The WAF1 promoter, including this p53-binding site, conferred p53-dependent inducibility upon a heterologous reporter gene. These studies define a gene whose expression is directly induced by p53 and that could be an important mediator of p53-dependent tumor growth suppression.
Similar articles
-
Mechanisms of regulation of WAF1/Cip1 gene expression in human breast carcinoma: role of p53-dependent and independent signal transduction pathways.Oncogene. 1994 Dec;9(12):3407-15. Oncogene. 1994. PMID: 7970699
-
p21WAF1 expression by an activator of protein kinase C is regulated mainly at the post-transcriptional level in cells lacking p53: important role of RNA stabilization.Biochem J. 1999 Feb 1;337 ( Pt 3)(Pt 3):607-16. Biochem J. 1999. PMID: 9895308 Free PMC article.
-
Relationships between G1 arrest and stability of the p53 and p21Cip1/Waf1 proteins following gamma-irradiation of human lymphoma cells.Cancer Res. 1995 Jun 1;55(11):2387-93. Cancer Res. 1995. PMID: 7757991
-
The p53 target Wig-1: a regulator of mRNA stability and stem cell fate?Cell Death Differ. 2011 Sep;18(9):1434-40. doi: 10.1038/cdd.2011.20. Epub 2011 Mar 11. Cell Death Differ. 2011. PMID: 21394102 Free PMC article. Review.
-
p53 function and dysfunction.Cell. 1992 Aug 21;70(4):523-6. doi: 10.1016/0092-8674(92)90421-8. Cell. 1992. PMID: 1505019 Review. No abstract available.
Cited by
-
Nanomedicine in HNSCC therapy-a challenge to conventional therapy.Front Pharmacol. 2024 Oct 14;15:1434994. doi: 10.3389/fphar.2024.1434994. eCollection 2024. Front Pharmacol. 2024. PMID: 39469621 Free PMC article. Review.
-
Re-appraising the evidence for the source, regulation and function of p53-family isoforms.Nucleic Acids Res. 2024 Nov 11;52(20):12112-12129. doi: 10.1093/nar/gkae855. Nucleic Acids Res. 2024. PMID: 39404067 Free PMC article. Review.
-
Modulation of Stemness and Differentiation Regulators by Valproic Acid in Medulloblastoma.bioRxiv [Preprint]. 2024 Sep 25:2024.09.23.614476. doi: 10.1101/2024.09.23.614476. bioRxiv. 2024. PMID: 39386542 Free PMC article. Preprint.
-
Evolution of the Cdk4/6-Cdkn2 system in invertebrates.Genes Cells. 2024 Nov;29(11):1037-1051. doi: 10.1111/gtc.13165. Epub 2024 Oct 8. Genes Cells. 2024. PMID: 39380239 Free PMC article.
-
FOXM1 Transcriptionally Co-Upregulates Centrosome Amplification and Clustering Genes and Is a Biomarker for Poor Prognosis in Androgen Receptor-Low Triple-Negative Breast Cancer.Cancers (Basel). 2024 Sep 18;16(18):3191. doi: 10.3390/cancers16183191. Cancers (Basel). 2024. PMID: 39335162 Free PMC article. Review.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous
